Difference between revisions of "Team:Waterloo/Practices/Human Practices"

m
Line 6: Line 6:
  
 
     <section id="id" title="Section Title">
 
     <section id="id" title="Section Title">
         <h2>Section Title</h2>
+
         <h2> The Product
        <p>
+
<h2> End-user consultations
        </p>
+
<h2> Design Criteria
 +
<h2> Safety Concerns
 +
<h3> Regulation
 +
 
 +
 +
<div class="panel panel-default">
 +
                <div class="panel-heading" role="tab" id="headingTwo">
 +
                    <h4 class="panel-title">
 +
                        <a class="collapsed" role="button" data-toggle="collapse" data-parent="#accordion" href="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
 +
                    Approval Process from Health Canada
 +
                    <span class="hidden-xs toggle-arrow pull-right">Panel Toggle</span>
 +
                    </a>
 +
                    </h4>
 +
                </div>
 +
                <div id="collapseTwo" class="panel-collapse collapse" role="tabpanel" aria-labelledby="headingTwo">
 +
                    <div class="panel-body">
 +
<h5>
 +
                      <p> In Canada, Health Canada controls the sale of genetically engineered food or products by the guidelines under division 28 (of part B) of the food and drugs regulations. The process of regulating a genetically engineered product is the same as regular products that is introduces for the first time. This is mainly because the Canadian food inspection agency focuses on characteristics expressed in each product rather than the methods used to introduce those characteristics. Independently of the place of origin of the product, genetic engineered products must be approved by Health Canada, the Canadian Food Inspection agency (CFIA) and Environment Canada. 
 +
<p>
 +
To obtain approval from such organizations a step by step process is followed and therefore outlined below:
 +
<p>
 +
<u>Step 1</u>: Submitting of pre-manufacture notification
 +
<br>Information about the product must be submitted to the Food Directorate of Health Products and Food Branch, Health Canada.  The information included in this notification has to contain:
 +
<ol type="a">
 +
<li>The name of the product and plane of manufacture</li>
 +
<li>Description of the product</li>
 +
<li>Method of manufacture</li>
 +
<li>Information about following laws and regulation of the product</li>
 +
<li>Proof that the novel food is safe for consumption</li>
 +
<li>Information of importance of product and estimated levels of consumption</li>
 +
<li>Sample of labelling of product</li>
 +
</ol>
 +
<p>
 +
<u>Step 2</u>: Submission of a safety assessment data package
 +
<br>Additional information can be submitted if needed for product. It could include extensive research concerning the safety and health side effects of consumption of the product.</li>
 +
<p>
 +
The information included in this assessment:
 +
<ol type="a">
 +
<li>Specific description and proof of genetic change</li>
 +
<li>Comparison of the novel food compared to non-modified version</li>
 +
<li>Potential side effects like toxins and allergic reactions</li>
 +
<li>Chemical and microbial considerations</li>
 +
</ol>
 +
<p>
 +
<u>Step 3</u>: A minimum of 45 days is required until it is decided whether the product is safe or requires additional information by the manufacturers. If more research is required the safety assessment data package must be submitted. This process could be as lengthy as 7 years since the research involves the investigation of  long-term effects as well as environmental impacts in extensive depth. </h5>
 +
                    </div>
 +
                </div>
 +
            </div>
 +
<h3> The need to account for unintended effects
 +
<h3> "Omic" studies as part of Risk Assessment
 +
 
 +
 
 +
 
 +
<h2> References
 
     </section>
 
     </section>
 
</div>
 
</div>
 
</html>
 
</html>
 
{{Waterloo_Footer}}
 
{{Waterloo_Footer}}

Revision as of 11:46, 18 September 2015

Human Practices

The Product

End-user consultations

Design Criteria

Safety Concerns

Regulation

In Canada, Health Canada controls the sale of genetically engineered food or products by the guidelines under division 28 (of part B) of the food and drugs regulations. The process of regulating a genetically engineered product is the same as regular products that is introduces for the first time. This is mainly because the Canadian food inspection agency focuses on characteristics expressed in each product rather than the methods used to introduce those characteristics. Independently of the place of origin of the product, genetic engineered products must be approved by Health Canada, the Canadian Food Inspection agency (CFIA) and Environment Canada.

To obtain approval from such organizations a step by step process is followed and therefore outlined below:

Step 1: Submitting of pre-manufacture notification
Information about the product must be submitted to the Food Directorate of Health Products and Food Branch, Health Canada. The information included in this notification has to contain:

  1. The name of the product and plane of manufacture
  2. Description of the product
  3. Method of manufacture
  4. Information about following laws and regulation of the product
  5. Proof that the novel food is safe for consumption
  6. Information of importance of product and estimated levels of consumption
  7. Sample of labelling of product

Step 2: Submission of a safety assessment data package
Additional information can be submitted if needed for product. It could include extensive research concerning the safety and health side effects of consumption of the product.

The information included in this assessment:

  1. Specific description and proof of genetic change
  2. Comparison of the novel food compared to non-modified version
  3. Potential side effects like toxins and allergic reactions
  4. Chemical and microbial considerations

Step 3: A minimum of 45 days is required until it is decided whether the product is safe or requires additional information by the manufacturers. If more research is required the safety assessment data package must be submitted. This process could be as lengthy as 7 years since the research involves the investigation of long-term effects as well as environmental impacts in extensive depth.

The need to account for unintended effects

"Omic" studies as part of Risk Assessment

References

Top